Ayşe Serap KARADAĞ, Serap GÜNEŞ BİLGİLİ, Temel TOMBUL, Ömer ÇALKA, İlhan ÇEÇEN, Ahmet Zübeyir BURAKGAZİ

Evaluation of brainstem auditory evoked potentials and their relationship with levels of thyroid autoantibodies in patients with vitiligo

Background/aim: Vitiligo is a common depigmenting disorder. The damage can also occur in similar ways to melanocytes within other organs. We evaluated the brainstem and auditory pathway functions by evaluating brainstem auditory evoked potentials (BAEPs) and whether there is any relationship between auditory functions and autoimmunity. Materials and methods: Forty patients with vitiligo and 20 healthy volunteers were enrolled. Thyroid functions and autoantibodies were examined and BAEP tests were assessed by a neurologist. Results: Antithyroid peroxidase (anti-TPO) and antithyroglobulin (anti-TGA) antibody positivity was higher in the patient group (P < 0.05). A negative correlation was detected between anti-TPO and lead III, IV, and V latency and I III interpeak latency (IPL) of the right ear together with lead IV latency and I V IPL of the left ear in the patient group. When each BAEP parameter was compared between the two groups, more abnormalities were detected in the V latency and III V IPL of the left ear together with IV and V latency of the right ear. Conclusion: In this study the presence of a correlation between increased anti-TGA and anti-TPO levels and BAEP parameters may be related to an autoimmune-mediated mechanism. However, further studies are needed to be performed in a large patient series.

PDF

___

1. Hong CK, Lee MH, Jeong KH, Cha CI, Yeo SG. Clinical analysis of hearing levels in vitiligo patients. Eur J Dermatol 2009; 19: 50-56.
2. Nikiforidis GC, Tsambaos DG, Karamitsos DS, Koutsojannis CC, Georgiou SV. Abnormalities of the auditory brainstem response in vitiligo. Scand Audiol 1993; 22: 97-100.
3. Özüer MZ, Şahiner T, Aktan Ş, Şanli B, Bayramoğlu İ. Auditory evoked potentials in vitiligo patients. Scand Audiol 1998; 27: 255-258.
4. Tosti A, Bardazzi F, Tosti G, Monti L. Audiologic abnormalities in cases of vitiligo. J Am Acad Dermatol 1987; 17: 230-233.
5. Elsaied MA, Abu Naga YA, Abdo IM. Evaluation of brain stem auditory evoked response in vitiligo patients. Journal of PanArab League of Dermatologists 2008; 19: 91-97.
6. Aydogan K, Turan OF, Onart S, Karadogan SK, Tunali S. Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol 2006; 31: 110-113.
7. Shalaby ME, El-Zarea GA, Nassar AI. Auditory function in vitiligo patients. Egyptian Dermatology Online Journal 2006; 2: 7.
8. Taieb A, Picardo M, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35.
9. Steel KP, Barkway C. Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development 1989; 107: 453-463.
10. Creel D, Garber SR, King RA, Witkop CJ Jr. Auditory brainstem anomalies in human albinos. Science 1980; 209: 1253-1255.
11. Biacabe B, Chevallier JM, Avan P, Bonfils P. Functional anatomy of auditory brainstem nuclei: application to the anatomical basis of brainstem auditory evoked potentials. Auris Nasus Larynx 2001; 28: 85-94.
12. Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousos GP. Increased prevalence of chronic autoimmune (Hashimotos) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol 2005; 53: 220- 223.
13. Yang Y, Lin X, Fu W, Luo X, Kang K. An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children. Clin Exp Dermatol 2010; 35: 706-710.
14. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol 2003; 131: 347- 354.
15. Bagić AI, Knowlton RC, Rose DF, Ebersole JS; ACMEGS Clinical Practice Guideline (CPG) Committee. American Clinical Magnetoencephalography Society Clinical Practice Guideline 3: MEG-EEG reporting. J Clin Neurophysiol 2011; 28: 362-363.
16. Walsh P, Kane N, Butler S. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry 2005; 76: 16-22.
17. Sharma L, Bhawan R, Jain RK. Hypoacusis in vitiligo. Indian J Dermatol Venereol Leprol 2004; 70: 162-164.
18. Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97: 1078-1080.
19. Kemp EH, Gawkrodger DJ, MacNeil S, Watson PF, Weetman AP. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol 1997; 109: 69-73.
20. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208-214.
21. Daneshpazhooh M, Mostofizadeh GM, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol 2006; 10: 6-13.
22. Arıcan Ö, Şaşmaz S, Çetinkaya A. Role of thyroid hormones in vitiligo type and progression. Türkderm 2003; 37: 269-273 (in Turkish with English summary).
23. Mocellin R, Walterfang M, Velakoulis D. Hashimotos encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 2007; 21: 799-811.
24. Tamagno G, Federspil G, Murialdo G. Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimotos encephalopathy). Intern Emerg Med 2006; 1: 15-23.
25. Schiess N, Pardo CA. Hashimotos encephalopathy. Ann NY Acad Sci 2008; 1142: 254-265.
26. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy syndrome or myth? Arch Neurol 2003; 60: 164-171.
27. Watemberg N, Greenstein D, Levine A. Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J Child Neurol 2006; 21: 1-5.
28. Gawron W, Pośpiech L, Noczyńska A, Orendorz-Fraczkowska K. Electrophysiological tests of the hearing organ in Hashimotos disease. J Pediatr Endocrinol Metab 2004; 17: 27- 32.
29. Sharma K, Behera JK, Kumar N, Sood S, Madan HS, Das S. Brainstem evoked potential in newly diagnosed patients of subclinical hypothyroidism. N Am J Med Sci 2015; 7: 131-134.